Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ICU MedicalICUI -0.02%81 Revenue per Share is $86.24 as of Jun. 2026. GuruFocus rates ICUI with a GF Score™ of 81/100 and a GF Value™ of $120.63 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 754 Medical Devices & Instruments companies, ICU Medical ranks worse than 63.26% on this metric.
ICU Medical's revenue per share for the
three
months ended in Jun. 2026 was $22.03.
ICU Medical's revenue per share for the trailing twelve months (TTM) ended in Jun. 2026 was $86.24.
Warning Sign:
ICU Medical Inc revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue Per Share Growth Rate of ICU Medical was -10.80% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was -2.10% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 10.60% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 15.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for ICU Medical's Revenue per Share or its related term are showing as below:
ICUI'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -2.5 Med: 17.5 Max: 46.4
Current: -2.1
During the past 13 years, ICU Medical's highest 3-Year average Revenue Per Share Growth Rate was 46.40% per year. The lowest was -2.50% per year. And the median was 17.50% per year.
ICUI's 3-Year Revenue Growth Rate is ranked worse than 63.26% of 754
companies
in the Medical Devices & Instruments industry
Industry Median: 3.7
vs ICUI: -2.10
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
ICU Medical Revenue per Share Related Terms
ICU Medical Revenue per Share Historical Data
* Premium members only.
The historical data trend for ICU Medical's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICUI vs NVST, MMSI, MMED: Revenue per Share Comparison
For the Medical Instruments & Supplies subindustry, ICU Medical's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's PS Ratio distribution charts can be found below:
* The bar in red indicates where ICU Medical's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
ICU Medical's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $86.24
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (ICUI) has a Revenue per Share of $86.24 as of Jun. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on ICU Medical and its competitors. According to the industry distribution chart, ICU Medical ranks #477 out of 754 companies in the Medical Devices & Instruments industry, placing it in the top 63.3%.
Is ICU Medical's Revenue per Share too high?
ICU Medical's current Revenue per Share is $86.24. The Medical Devices & Instruments industry median Revenue per Share is 3.70. ICU Medical's value of $86.24 is 2230.8% above this industry median. Based on the distribution chart, ICU Medical ranks #477 out of 754 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ICU Medical has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ICU Medical's Revenue per Share compare to NVST and MMSI?
According to the Medical Devices & Instruments industry distribution chart, ICU Medical ranks #477 out of 754 companies for Revenue per Share. This places ICU Medical in the lower half of its industry. The industry median Revenue per Share is 3.70. ICU Medical's value of $86.24 is 2230.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Medical Devices & Instruments company?
The median Revenue per Share among Medical Devices & Instruments companies is 3.70, based on 754 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ICU Medical's current Revenue per Share of $86.24 is 2230.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on ICU Medical and its competitors. For the Medical Devices & Instruments industry, the median Revenue per Share is 3.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICU Medical's current Revenue per Share is $86.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Medical stock overvalued right now?
Based on GuruFocus' analysis, ICU Medical (ICUI) is currently considered Significantly Overvalued. The stock's GF Value™ is $120.63, compared to a current price of $182.50 — trading 51.3% above its estimated fair value. The current Revenue per Share is $86.24 and 2230.8% above the Medical Devices & Instruments industry median of 3.70. ICU Medical's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For ICU Medical (ICUI), the current Revenue per Share is $86.24 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICU Medical (ICUI) Overvalued in 2026?
Based on GuruFocus' analysis, ICU Medical stock appears to be overvalued.
The current stock price of $182.50 is trading 51.3% above its estimated GF Value™ of $120.63.
GuruFocus considers ICU Medical to be Significantly Overvalued.
Key valuation signals for ICUI:
Revenue per Share: $86.24
GF Value™: $120.63 vs. price of $182.50 (51.3% above fair value)
Industry Position: 2230.8% above the Medical Devices & Instruments median (#477 of 754)
No single metric tells the full story. See the ICUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
81GF Score
Get the complete analysis for ICUI
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ICUI has been successfully added to your 
